• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

连续测定白细胞介素6作为类风湿关节炎全身疾病的一项指标。

Serial estimation of interleukin 6 as a measure of systemic disease in rheumatoid arthritis.

作者信息

Dasgupta B, Corkill M, Kirkham B, Gibson T, Panayi G

机构信息

Rheumatology Unit, United Medical School, Guy's Hospital, London, UK.

出版信息

J Rheumatol. 1992 Jan;19(1):22-5.

PMID:1556695
Abstract

Disease activity in rheumatoid arthritis (RA) is frequently associated with a marked acute phase response, thrombocytosis, hypergammaglobulinemia and the presence of rheumatoid factors (RF). Interleukin 6 (IL-6) is a cytokine that stimulates hepatocytes to produce acute phase reactants and B lymphocytes to produce immunoglobulin. We measured serum IL-6 in patients with active RA during induction of intramuscular gold therapy. Levels of IL-6 correlated strongly with the erythrocyte sedimentation rate and RF titers and to a lesser degree with platelet counts. It may, therefore, be responsible for many of the systemic manifestations of RA and its measurement in the serum may be a convenient and reproducible variable for the assessment of disease activity in this very common disease.

摘要

类风湿关节炎(RA)的疾病活动通常与明显的急性期反应、血小板增多、高球蛋白血症以及类风湿因子(RF)的存在有关。白细胞介素6(IL-6)是一种细胞因子,可刺激肝细胞产生急性期反应物,并刺激B淋巴细胞产生免疫球蛋白。我们在肌肉注射金制剂治疗诱导期对活动期RA患者的血清IL-6进行了测量。IL-6水平与红细胞沉降率和RF滴度密切相关,与血小板计数的相关性较小。因此,它可能是RA许多全身表现的原因,血清中IL-6的测量可能是评估这种常见疾病疾病活动的一个方便且可重复的指标。

相似文献

1
Serial estimation of interleukin 6 as a measure of systemic disease in rheumatoid arthritis.连续测定白细胞介素6作为类风湿关节炎全身疾病的一项指标。
J Rheumatol. 1992 Jan;19(1):22-5.
2
Interleukin 8 and monocyte chemoattractant protein-1 in patients with juvenile rheumatoid arthritis. Relation to onset types, disease activity, and synovial fluid leukocytes.青少年类风湿关节炎患者的白细胞介素8和单核细胞趋化蛋白-1。与发病类型、疾病活动度及滑液白细胞的关系。
J Rheumatol. 1999 Feb;26(2):425-31.
3
[Correlation of serum IgA levels with serum IgG levels, erythrocyte sedimentation rate and platelet counts in 98 patients with rheumatoid arthritis].98例类风湿关节炎患者血清IgA水平与血清IgG水平、红细胞沉降率及血小板计数的相关性研究
Rinsho Byori. 1999 Jul;47(7):665-8.
4
Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis.类风湿关节炎中免疫系统激活及炎症活动与动脉粥样血栓形成性疾病和动脉粥样硬化标志物的关系
J Rheumatol. 2002 May;29(5):875-82.
5
Spontaneous synthesis of IgM rheumatoid factor by blood mononuclear cells from patients with rheumatoid arthritis: effect of treatment with gold salts or D-penicillamine.类风湿关节炎患者血液单核细胞自发合成 IgM 类风湿因子:金盐或 D-青霉胺治疗的效果
J Rheumatol. 1984 Feb;11(1):17-21.
6
Relationship of soluble interleukin-2-receptor and interleukin-6 with class-specific rheumatoid factors during low-dose methotrexate treatment in rheumatoid arthritis.
Rev Rhum Engl Ed. 1997 Feb;64(2):89-94.
7
Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.风湿性疾病中基质金属蛋白酶MMP - 3和MMP - 1、金属蛋白酶组织抑制剂1(TIMP - 1)以及MMP - 1/TIMP - 1复合物的循环水平。与类风湿关节炎临床活动度及其他替代标志物的相关性。
J Rheumatol. 1999 Feb;26(2):251-8.
8
Apoptotic effect of rituximab on peripheral blood B cells in rheumatoid arthritis.利妥昔单抗对类风湿关节炎患者外周血B细胞的凋亡作用
Scand J Immunol. 2004 Jul-Aug;60(1-2):209-18. doi: 10.1111/j.0300-9475.2004.01441.x.
9
The photometric latex test for rheumatoid factors in patients with rheumatoid arthritis. II. Clinical evaluation.类风湿关节炎患者类风湿因子的乳胶比浊试验。II. 临床评估。
Z Rheumatol. 1978 Mar-Apr;37(3-4):112-22.
10
Decreased suppressive B cell factor (SBF) in rheumatoid arthritis: evidence for a defect in B cell autoregulation.类风湿关节炎中抑制性B细胞因子(SBF)减少:B细胞自身调节缺陷的证据。
J Immunol. 1986 Mar 15;136(6):2151-7.

引用本文的文献

1
Comparison of the inhibitory effect of tocilizumab and etanercept on the progression of joint erosion in rheumatoid arthritis treatment.比较托珠单抗和依那西普对类风湿关节炎治疗中关节侵蚀进展的抑制作用。
Sci Rep. 2022 Oct 20;12(1):17524. doi: 10.1038/s41598-022-22152-w.
2
IL-6 is involved in thoracic ossification of the ligamentum flavum.白细胞介素-6 参与黄韧带的胸椎骨化。
PLoS One. 2022 Jul 29;17(7):e0272357. doi: 10.1371/journal.pone.0272357. eCollection 2022.
3
Inhibitory Effects of Cold Atmospheric Plasma on Inflammation and Tumor-Like Feature of Fibroblast-Like Synoviocytes from Patients with Rheumatoid Arthritis.
冷大气等离子体对类风湿关节炎患者成纤维样滑膜细胞炎症及肿瘤样特征的抑制作用
Inflammation. 2022 Dec;45(6):2433-2448. doi: 10.1007/s10753-022-01703-3. Epub 2022 Jun 17.
4
Predictive factors for effective selection of Interleukin-6 inhibitor and tumor necrosis factor inhibitor in the treatment of rheumatoid arthritis.预测类风湿关节炎治疗中白细胞介素 6 抑制剂和肿瘤坏死因子抑制剂有效选择的因素。
Sci Rep. 2020 Oct 6;10(1):16645. doi: 10.1038/s41598-020-73968-3.
5
Salivary interleukin 6, interleukin 8, interleukin 17A, and tumour necrosis factor α levels in patients with periodontitis and rheumatoid arthritis.牙周炎和类风湿性关节炎患者唾液中白细胞介素6、白细胞介素8、白细胞介素17A和肿瘤坏死因子α的水平
Cent Eur J Immunol. 2019;44(3):269-276. doi: 10.5114/ceji.2019.89601. Epub 2019 Sep 30.
6
Tocilizumab in the treatment of rheumatoid arthritis: an evidence-based review and patient selection.托珠单抗治疗类风湿关节炎:基于证据的综述与患者选择
Drug Des Devel Ther. 2018 Dec 19;13:57-70. doi: 10.2147/DDDT.S150580. eCollection 2019.
7
Sarilumab: patient-reported outcomes in rheumatoid arthritis.托珠单抗:类风湿关节炎患者报告的结局
Patient Relat Outcome Meas. 2018 Aug 20;9:275-284. doi: 10.2147/PROM.S147286. eCollection 2018.
8
Methotrexate upregulates circadian transcriptional factors PAR bZIP to induce apoptosis on rheumatoid arthritis synovial fibroblasts.甲氨蝶呤上调 circadian 转录因子 PAR bZIP 诱导类风湿关节炎滑膜成纤维细胞凋亡。
Arthritis Res Ther. 2018 Mar 22;20(1):55. doi: 10.1186/s13075-018-1552-9.
9
Profile of sarilumab and its potential in the treatment of rheumatoid arthritis.托珠单抗简介及其在类风湿关节炎治疗中的潜力。
Drug Des Devel Ther. 2017 May 24;11:1593-1603. doi: 10.2147/DDDT.S100302. eCollection 2017.
10
The -174G/C Interleukin-6 Gene Promoter Polymorphism as a Genetic Marker of Differences in Therapeutic Response to Methotrexate and Leflunomide in Rheumatoid Arthritis.-174G/C白细胞介素-6基因启动子多态性作为类风湿关节炎中对甲氨蝶呤和来氟米特治疗反应差异的遗传标志物
Biomed Res Int. 2016;2016:4193538. doi: 10.1155/2016/4193538. Epub 2016 Sep 21.